Non-motor symptoms in Parkinson disease patients Hospital de San José, Bogotá DC. Colombia

Síntomas no motores en pacientes con enfermedad de Parkinson Hospital de San José, Bogotá, DC Colombia

Introduction: Parkinson's disease (PD) is the second most common neurodegenerative disorder with a prevalence of 4.7 per 1000 people in Colombia. Non-motor symptoms (NMS) are included in the spectrum for they lead to increased morbility and impaired quality of life. Overall Objective: to describe the frequency of NMS in patients diagnosed with PD who attend the neurology outpatient clinic at Hospital de San José de Bogotá DC. Methods: series of adults who consulted between April and September 2011 who met the diagnostic criteria for PD according to the UK Brain Data Bank. The PD NMS quest questionnaire validated in Spanish was used. Results: fifty-five patients, men 61.8%, average age 68 years (SD 9.8) were surveyed. A clinical course equal to or less than 5 years was documented in 51 % and 85.5% were classified between stages I and II according to the Hoehn and Yahr scale. The most common NMS are: urgent urination 76.4%, melancholia 74.5%, unpleasant sensation in the Iegs during the night or need to move the legs 67.2% and having trouble remembering things 61.8%. Conclusions: NMS are often found in our population. The urinary tract is most commonly involved. Patient should be asked about NMS in order to offer a comprehensive management. Further studies on our population evaluating quality of life are required.

1. Braak H, Del TK. Invited Article: Nervous system pathology in sporadic Parkin­ son disease. Neurology. 2008 May 13;70(20):1916-25.
2. Nebe A, Ebersbach G. Selective diplopía in Parkinson's disease: a special subty­ pe of visual hallucination?. Mov Disord. 2007 Jun 15 ;22(8):1175-8.
3. Argandoña-Palacios L, Perona-Moratalla AB, Hemandez-Femandez F, Diaz­ Maroto 1, Garcia-Munozguren S. [Non-motor disorders in Parkinson's disease: introduction and general features]. Rev Neurol. 2010 Feb 8; 50 Suppl 2:Sl -S5.
4. Pradilla AG, Vesga AB, Lean-Sarmiento FE. [National neuroepidemiolo­ gical study in Colombia (EPINEURO)]. Rev Panam Salud Publica. 2003 Aug;l4(2):104-1J.
5. Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 Mar;24(2):197-211.
Marco-Llorente J, Rojo-Martinez E. [Other non-motor disorders in Parkinson's disease]. Rev Neurol. 2010 Feb 8; 50 Suppl 2:S75-S83.
7. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, et al. Intemational study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology. 2009 Nov 10; 73(19):1584-91.
8. Calabresi P, Picconi B, Pametti L, Di FM. A convergent model for cognitive dysfunctions in Parkinson's disease: the critica! dopamine-acetylcholine synaptic balance. Lancet Neurol. 2006 Nov; 5(11):974-83.
9. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. Intemational multicenter pilotstudy of the first comprehensive self completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord. 2006 Ju!; 21(7):916-23.
10. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an intemational pilot study. Mov Disord. 2007 Oct 15; 22(13):1901-11.
11. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an intemational study using the nonmotor symptoms ques­ tionnaire. Mov Disord. 2010 Apr 30; 25(6):697-701.
12. Dawson TM, Dawson VL. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest. 2003 Jan;l 11(2):145-51.
13. Erro ME, Moreno MP, Zandio B. [Pathophysiological bases of the non-motor symptoms in Parkinson's disease]. Rev Neurol. 2010 Feb 8; 50 Suppl 2:S7-13.
14. Forjaz MJ, Frades-Payo B, Martinez-Martin P. [The current state of the art con­ cerning quality of life in Parkinson's disease: II. Deterrnining and associated fac­ tors]. Rev Neurol. 2009 Dec 16; 49(12):655-60.
15. Gonzalez-Fernandez J, Prieto-Albín R, Velasco-Palacios L, Jorge-Roldan S, Cubo-Delgado E. [Digestivedisorders in Parkinson'sdisease: dysphagia and sia­ lorrhea]. Rev Neurol. 2010 Feb 8; 50 Suppl 2:S51-S54.
16. Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficien­ cy in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 1999 Sep;7(3):169-74.
17. Mondragon-Rezola E, Arratibel-Echarren 1, Ruiz-Martinez J, Marti-Masso JF. [Sleep disorders in Parkinson's disease: insomnia and sleep fragmentation, dayti­ me hypersomnia, alterations to the circadian rhythm and sleep apnea syndrome]. Rev Neurol. 2010 Feb 8;50 Supp.l 2:S21-S26.
18. Jauregui-Barrutia A, Tijero-Merino B, Gomez-Esteban JC, Zarranz JJ. [Sleep disorders in Parkinson's disease: REM sleep bebaviour disorder and restless legs syndrome]. Rev Neurol. 20!0 Feb 8;50 Suppl 2:Sl 5-S19.
19. Jellinger KA. A critica! reappraisal of curren! staging of Lewy-related pathology in human brain. Acta Neuropathol. 2008 Jul;l16(1):1-16.
20. Vazquez-Saanchez F, Rodriguez-Martinez E, Ares-Luque A. [Urinary disorders, sexual dysfunction and hypersexuality in Parkinson's disease]. Rev Neurol. 2010 Feb 8; 50 Suppl 2:S27-S3l.
21. Zesiewicz TA, Sullivan KL, Amulf 1, Chaudburi KR, Morgan JC, Gronseth GS, et al. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the QuaJity Standards Subcommittee of the American Academy of Neu­ rology. Neurology. 2010 Mar 16;74(11):924-31.